Financials
- Market Capitalization 12.64 B
- Employee 3 221
- Founded N/A
- CEO Alexander Hardy
- Website www.biomarin.com
- Headquarter Delaware, United States
- FIGI BBG000CZWZ05
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
33.02
Fiyat/satışlar oranı
3.64
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 757 | EXEL Exelixis, Inc. - Common Stock | 55.26 USD | -1.50% | +2.83% | -2.11% | +41.55% | 13.69 B USD | ||
| 802 | CORT Corcept Therapeutics Incorporated - Common Stock | 116.93 USD | -2.40% | -3.75% | +23.08% | +59.37% | 12.64 B USD | ||
| 806 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 543.69 USD | +0.89% | +3.94% | +0.39% | +28.35% | 12.56 B USD | ||
| 809 | ARWR Arrowhead Pharmaceuticals, Inc. - Common Stock | 88.59 USD | -0.59% | +0.50% | +3.54% | +126.57% | 12.51 B USD |